Caricamento...
Doxorubicin‐induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database
BACKGROUND: Doxorubicin is a typical anticancer drug that causes cardiomyopathy and heart failure (HF). The aim of our study was to investigate incidence, risk factors for doxorubicin‐induced HF in Korean cancer patients and their survival rate, utilizing a nationwide population‐based cohort. METHOD...
Salvato in:
| Pubblicato in: | Cancer Med |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308087/ https://ncbi.nlm.nih.gov/pubmed/30453386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1886 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|